Together, Let’s Drive Improved Drug Access for Rare Diseases
Canada’s rare disease patient community is leveraging a $1.5-billion drug strategy to drive accelerated sustainable drug access for rare diseases and beyond. In March 2023, the federal government announced $1.5 billion over three years to implement Canada’s Rare Disease Drug Strategy. The Canadian Organization for Rare Disorders (CORD) applauded this significant step toward fulfillment of...
2 min read
Health Insight
